These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

66 related items for PubMed ID: 1480089

  • 1. Site-directed mutagenesis of type I collagen: effect on susceptibility to collagenase.
    Krane SM, Jaenisch R.
    Matrix Suppl; 1992; 1():64-7. PubMed ID: 1480089
    [Abstract] [Full Text] [Related]

  • 2. Is collagenase (matrix metalloproteinase-1) necessary for bone and other connective tissue remodeling?
    Krane SM.
    Clin Orthop Relat Res; 1995 Apr; (313):47-53. PubMed ID: 7641497
    [Abstract] [Full Text] [Related]

  • 3. Susceptibility of type I collagen containing mutated alpha 1(1) chains to cleavage by human neutrophil collagenase.
    Hasty KA, Wu H, Byrne M, Goldring MB, Seyer JM, Jaenisch R, Krane SM, Mainardi CL.
    Matrix; 1993 May; 13(3):181-6. PubMed ID: 8326908
    [Abstract] [Full Text] [Related]

  • 4. Mutations in the COL1A2 gene of type I collagen that result in nonlethal forms of osteogenesis imperfecta.
    Wenstrup RJ, Lever LW, Phillips CL, Quarles LD.
    Am J Med Genet; 1993 Jan 15; 45(2):228-32. PubMed ID: 8456807
    [Abstract] [Full Text] [Related]

  • 5. Generation of collagenase-resistant collagen by site-directed mutagenesis of murine pro alpha 1(I) collagen gene.
    Wu H, Byrne MH, Stacey A, Goldring MB, Birkhead JR, Jaenisch R, Krane SM.
    Proc Natl Acad Sci U S A; 1990 Aug 15; 87(15):5888-92. PubMed ID: 2165607
    [Abstract] [Full Text] [Related]

  • 6. Amino acid sequence environment modulates the disruption by osteogenesis imperfecta glycine substitutions in collagen-like peptides.
    Yang W, Battineni ML, Brodsky B.
    Biochemistry; 1997 Jun 10; 36(23):6930-5. PubMed ID: 9188687
    [Abstract] [Full Text] [Related]

  • 7. (G586V) substitutions in the alpha 1 and alpha 2 chains of collagen I: effect of alpha-chain stoichiometry on the phenotype of osteogenesis imperfecta?
    Lund AM, Skovby F, Schwartz M.
    Hum Mutat; 1997 Jun 10; 9(5):431-6. PubMed ID: 9143923
    [Abstract] [Full Text] [Related]

  • 8. Mutations in type I collagen genes resulting in osteogenesis imperfecta in humans.
    Gajko-Galicka A.
    Acta Biochim Pol; 2002 Jun 10; 49(2):433-41. PubMed ID: 12362985
    [Abstract] [Full Text] [Related]

  • 9. Four new cases of lethal osteogenesis imperfecta due to glycine substitutions in COL1A1 and genes. Mutations in brief no. 152. Online.
    Mottes M, Gomez Lira M, Zolezzi F, Valli M, Lisi V, Freising P.
    Hum Mutat; 1998 Jun 10; 12(1):71-2. PubMed ID: 10627137
    [Abstract] [Full Text] [Related]

  • 10. Inherited disorders of collagen gene structure and expression.
    Byers PH.
    Am J Med Genet; 1989 Sep 10; 34(1):72-80. PubMed ID: 2683783
    [Abstract] [Full Text] [Related]

  • 11. A cysteine for glycine substitution at position 1017 in an alpha 1(I) chain of type I collagen in a patient with mild dominantly inherited osteogenesis imperfecta.
    Labhard ME, Wirtz MK, Pope FM, Nicholls AC, Hollister DW.
    Mol Biol Med; 1988 Dec 10; 5(3):197-207. PubMed ID: 3244312
    [Abstract] [Full Text] [Related]

  • 12. Molecular heterogeneity in osteogenesis imperfecta type I.
    Willing MC, Pruchno CJ, Byers PH.
    Am J Med Genet; 1993 Jan 15; 45(2):223-7. PubMed ID: 8456806
    [Abstract] [Full Text] [Related]

  • 13. Intrafamilial variable expressivity of osteogenesis imperfecta due to mosaicism for a lethal G382R substitution in the COL1A1 gene.
    Cohen-Solal L, Zolezzi F, Pignatti PF, Mottes M.
    Mol Cell Probes; 1996 Jun 15; 10(3):219-25. PubMed ID: 8799376
    [Abstract] [Full Text] [Related]

  • 14. Perinatal lethal osteogenesis imperfecta in transgenic mice bearing an engineered mutant pro-alpha 1(I) collagen gene.
    Stacey A, Bateman J, Choi T, Mascara T, Cole W, Jaenisch R.
    Nature; 1988 Mar 10; 332(6160):131-6. PubMed ID: 2450280
    [Abstract] [Full Text] [Related]

  • 15. Y-position cysteine substitution in type I collagen (alpha1(I) R888C/p.R1066C) is associated with osteogenesis imperfecta/Ehlers-Danlos syndrome phenotype.
    Cabral WA, Makareeva E, Letocha AD, Scribanu N, Fertala A, Steplewski A, Keene DR, Persikov AV, Leikin S, Marini JC.
    Hum Mutat; 2007 Apr 10; 28(4):396-405. PubMed ID: 17206620
    [Abstract] [Full Text] [Related]

  • 16. Severity of osteogenesis imperfecta and structure of a collagen-like peptide modeling a lethal mutation site.
    Radmer RJ, Klein TE.
    Biochemistry; 2004 May 11; 43(18):5314-23. PubMed ID: 15122897
    [Abstract] [Full Text] [Related]

  • 17. The importance of proline residues in the structure, stability and susceptibility to proteolytic degradation of collagens.
    Krane SM.
    Amino Acids; 2008 Nov 11; 35(4):703-10. PubMed ID: 18431533
    [Abstract] [Full Text] [Related]

  • 18. Thermal stability and folding of the collagen triple helix and the effects of mutations in osteogenesis imperfecta on the triple helix of type I collagen.
    Bächinger HP, Morris NP, Davis JM.
    Am J Med Genet; 1993 Jan 15; 45(2):152-62. PubMed ID: 8456797
    [Abstract] [Full Text] [Related]

  • 19. A targeted mutation at the known collagenase cleavage site in mouse type I collagen impairs tissue remodeling.
    Liu X, Wu H, Byrne M, Jeffrey J, Krane S, Jaenisch R.
    J Cell Biol; 1995 Jul 15; 130(1):227-37. PubMed ID: 7790374
    [Abstract] [Full Text] [Related]

  • 20. Three arginine to cysteine substitutions in the pro-alpha (I)-collagen chain cause Ehlers-Danlos syndrome with a propensity to arterial rupture in early adulthood.
    Malfait F, Symoens S, De Backer J, Hermanns-Lê T, Sakalihasan N, Lapière CM, Coucke P, De Paepe A.
    Hum Mutat; 2007 Apr 15; 28(4):387-95. PubMed ID: 17211858
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.